Human Recombinant IFN-A 2A (from E. coli)

New Product

Human Recombinant IFN-A 2A (from E. coli)

New Product

Interferon-alpha 2a (IFN-α 2a) is a type I interferon made by leukocytes during viral infection. The JAK-STAT pathway mediates the antiviral and anti-cell proliferation activities of IFN-α 2a. IFN-α proteins are widely used as standard treatments during antiviral and antineoplastic therapies. The IFN-α 2a variant differs from IFN-α 2b by one amino acid.

High quality
Low endotoxin
Affordable

: For research use only.

Conjugation:
Unconjugated
Protein Function:
Cytokine
Protein/Peptide Type:
Recombinant
Source:
E. coli
Species:
Human
Storage Conditions:
–20 °C
Endotoxin Content:
Endotoxin LAL (EU/µg) ≤1
Biological Activity:
Bioactivity assay: Viral CPE assay using EMC virus on A549 cells; ED50 ≤0.005 ng/ml; Bioactivity ≥2.0×10⁸ units/mg
Gene ID:
P01563
Reconstitution Instructions:
Sterile water at 0.1 mg/ml
Endotoxin-free:
N
Carrier-Free:
Y
Protease-free:
N
Animal-Free:
N
Protein Synonyms:
Type I Interferon|Alpha 2
Protein/Peptide Name:
IFN-A 2A
Purity:
≥95%
Molecular Weight:
19.4 kDa
Sequence:
MCDLPQTHSL GSRRTLMLLA QMRKISLFSC LKDRHDFGFP QEEFGNQFQK AETIPVLHEM IQQIFNLFST KDSSAAWDET LLDKFYTELY QQLNDLEACV IQGVGVTETP LMKEDSILAV RKYFQRITLY LKEKKYSPCA WEVVRAEIMR SFSLSTNLQE SLRSKE
Endotoxin Level:
Low
Formulation:
0.1% Trifluoroacetic acid (TFA)
Nuclease-free:
N
Grade:
RUO
Shipping Temperature:
RT
Tested Applications:
Bioassay